Hero MotoCorp (NSE: HEROMOTOCO) May dispatches rise to 5.7 lakh units as VIDA and exports sharpen growth story
Read More Pharma Industry News Why oncology clinicians are watching EOM613’s effect on muscle loss, appetite, and chemotherapy readiness Find out how EOM613 could reshape cancer cachexia treatment as EOM Pharmaceutical Holdings advances its FDA-cleared Phase 2a study. bySoujanya RaviMay 29, 2026